Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Amgen Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
AMGN
Nasdaq
2830
www.amgen.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Amgen Inc.
Amgen or Merck: Which Drugmaker Has the Stronger Dividend Growth Story?
- Sep 19th, 2026 6:55 am
Amgen (AMGN) Stock Sees Modest Fair Value Lift As Analysts Weigh Pipeline Risks
- Sep 18th, 2026 8:09 pm
Amgen (AMGN) Surpasses Market Returns: Some Facts Worth Knowing
- Sep 18th, 2026 3:50 pm
What Would It Take For Eli Lilly Stock To Keep Climbing?
- Sep 18th, 2026 3:23 pm
Top Research Reports for AMD, Linde & Amgen
- Sep 18th, 2026 2:28 pm
Can Sotyktu's Long-Term PsA Data Boost Bristol Myers' Prospects?
- Sep 18th, 2026 1:17 pm
A Failed Cholesterol Drug Raises the Stakes for Amgen (AMGN) and Eli Lilly (LLY) Too
- Sep 17th, 2026 5:57 pm
Can Volume Keep Covering Eli Lilly's Price Cuts?
- Sep 17th, 2026 1:17 pm
Amgen Stock Fell 10% in a Day on a Drug It Doesn’t Own. Is It Time to Buy AMGN?
- Sep 17th, 2026 8:26 am
Why This Biotech Stock Just Got a Rare Double Upgrade
- Sep 16th, 2026 2:25 pm
ALVO Stock Jumps On Double Upgrade — Why Barclays Sees A 59% Upside
- Sep 16th, 2026 12:33 pm
Critics Warn of AI-Driven Disaster. Anthropic and Novo Are Betting on the Opposite.
- Sep 16th, 2026 12:27 pm
Worried About a Market Crash? This Dividend Stock Outperformed as the S&P 500 Sank in Both 2008 and 2022
- Sep 16th, 2026 12:20 pm
Sjögren's Syndrome Market to Witness Sustained Growth During the Forecast Period (2026-2036) Due to the Development of Targeted Immunotherapies, FcRn Inhibitors, TYK2 Inhibitors, and Cell Therapies | DelveInsight
- Sep 16th, 2026 8:31 am
September Syndrome in Full Swing: 3 Picks to Safeguard Your Portfolio
- Sep 16th, 2026 5:59 am
Amgen Highlights MariTide, IMDELLTRA Pipeline Progress and Growth Priorities
- Sep 15th, 2026 11:02 pm
4 Defensive Stocks to Take Refuge in as Consumer Sentiment Plummets
- Sep 15th, 2026 6:08 am
Leading Biotech Selects Veeva Vault CRM Globally
- Sep 15th, 2026 5:03 am
Is This LLY Stock Dip Big Enough To Be Worth Buying?
- Sep 14th, 2026 2:09 pm
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock
- Sep 14th, 2026 7:00 am
Scroll